A Founder’s Letter: Why I Built Metamorphosis on Clinical Science — And What We Just Filed Seven Patents to Protect
I left a career in law not because I stopped believing in evidence — but because I found an industry that desperately needed it. Today, Metamorphosis Light Therapy announces seven...
The short answer: Metamorphosis Light Therapy was founded on a single principle — that the beauty industry deserved the same standard of evidence demanded in clinical medicine. Every device we make carries FDA 510(k) clearance, and every clearance is substantiated where needed by independent biometric clinical studies using pharmaceutical-grade instrumentation. In 2026, we filed seven provisional utility patents covering a new generation of photobiomodulation-activated skincare — the next evolution of that founding commitment.
I left law not because I stopped believing in evidence — but because I found an industry that desperately needed it
I spent years as a licensed attorney in South Carolina, working in real estate and contracts — a world built entirely on documentation, verification, and proof. Every claim had to be substantiated. Every assertion had to be defensible. Evidence was not optional; it was the foundation of everything.
When I turned my attention to the beauty technology space, I was genuinely shocked by what I found. Devices making clinical-sounding claims with no regulatory clearance. Brands using the language of science — collagen, elastin, cellular regeneration — with no independent data to support them. A marketplace flooded with confidence and empty of accountability.
I didn’t see a beauty opportunity. I saw a credibility gap. And I learned how to close it.
That is why I founded Metamorphosis Light Therapy — not to follow the beauty industry, but to hold it to a higher standard. The standard I learned in law: if you can’t prove it, you don’t say it.
What “clinically proven” actually means at Metamorphosis
In the consumer LED device category, the phrase “clinically proven” is used so loosely it has become nearly meaningless. Self-reported surveys. Internal testing. Photographs taken under carefully controlled lighting. These are not clinical studies — they are marketing tools dressed in scientific language.
At Metamorphosis, clinical validation means something specific and verifiable:
• Independent biometric studies conducted by a professional cosmetic efficacy laboratory under dermatologist supervision
• 84-day duration with multiple measurement time-points to confirm progressive, sustained results
• Gold-standard instrumentation — the same category of tools used in pharmaceutical and dermatological research — including 3D surface imaging, mechanical elasticity measurement, melanin and erythema analysis, and hydration profiling
• Statistically significant results reported with p-values, not just percentages
• FDA 510(k) clearance for each device
The results speak for themselves. LushLips Transformation achieved a 42–46% reduction in perioral wrinkle density with 83% of participants showing visible improvement in independent dermatologist evaluations. MagicMoon Eye Evolution produced a statistically significant 7.6% decrease in periorbital surface roughness (p=0.044) with 74% of participants showing measurable improvement confirmed by 3D imaging.
These are not marketing numbers. They are instrument-verified, dermatologist-confirmed, independently conducted results. And they are the reason Harper’s Bazaar named LushLips one of the six best red light therapy devices for lips in 2026 — without us asking, without an advertisement, and without any prior knowledge it was coming.
Why every Metamorphosis product exists within a clinical ecosystem
From the beginning, I designed Metamorphosis not as a collection of products but as a clinical ecosystem — each device cleared for a specific indication, each companion product formulated to amplify the biological mechanism the device activates.
Our FDA-cleared device portfolio covers the three zones of facial aging that matter most:
• LushLips Transformation (FDA 510(k) K213024) — perioral wrinkles and lip-line treatment
• MagicMoon Eye Evolution (FDA 510(k) K240089) — periorbital wrinkles, dark circles, and puffiness
• MorphoGlow (FDA 510(k) K230720) — 5-in-1 full-face lifting, toning, and radiance
• RubyRadiance (FDA 510(k) K203271) — serum application for wrinkled areas and acne
• SuperStar Pimple Patches (FDA 510(k) K230720) — mild to moderate inflammatory acne
Each device is supported by safety certifications across FCC, UL, California Proposition 65, MSDS, and UN 38.3 lithium battery standards — a certification stack that is genuinely uncommon in the consumer LED category.
But devices alone were never the complete vision. Photobiomodulation works at the mitochondrial level — stimulating cytochrome c oxidase, increasing ATP production, upregulating collagen synthesis. I wanted companion products that understood that mechanism and worked with it, not around it.
That conviction led directly to what we are announcing today.
Announcement: Seven Provisional Utility Patents Filed in 2026
In 2026, Metamorphosis Light Therapy filed seven provisional utility patents covering a new generation of photobiomodulation-activated skincare. These filings represent the next evolution of our founding commitment — taking the same clinical rigor that produced our FDA-cleared devices and applying it to the formulations designed to work alongside them.
I am not going to describe every patent in detail — that is not how intellectual property strategy works, and as an attorney I know better than most that the value of a provisional filing lies in what it protects, not what it announces. But I can tell you this: every one of these seven filings exists because of a problem I identified in the market and a solution we built from the science up.
The category we are entering does not yet exist in any meaningful way. Every red light therapy serum currently on the market is, in essence, a hydrating gel with a marketing story. What we have formulated is something categorically different — and the patents reflect that difference.
Introducing SkinEXcellence Energize — the first serum built for the light
I can share one product from the SkinEXcellence line because it represents everything we believe about what photobiomodulation-activated skincare should be.
SkinEXcellence Energize Light Therapy Accelerator Serum is the first serum formulated around the actual science of photobiomodulation — specifically targeting cytochrome c oxidase, the mitochondrial enzyme that red light activates at the cellular level.
Where competitors formulate with coconut oil and shea butter that physically block photon penetration, SkinEXcellence Energize is engineered with an optically transparent base designed to transmit light, not impede it. The active ingredient complex directly primes the mitochondrial electron transport chain before your device ever turns on:
• CoQ10 (Ubiquinol) — the mitochondrial electron carrier that amplifies cellular energy production
• Astaxanthin — a potent antioxidant that protects against photooxidative stress during treatment
• Adenosine — supports ATP synthesis and cellular repair at the site of light activation
• Clinical-dose 5% Niacinamide complex — barrier support, brightening, and anti-inflammatory action
• Four peptides including GHK-Cu Copper Peptide and Matrixyl Synthe’6 — true collagen signaling, not surface conditioning
• Multi-weight Hyaluronic Acid — hydration delivered at both the surface and dermal level
• Reduced Glutathione and Caffeine — completing the cellular environment for maximum photobiomodulation response
No oils. No occlusives. No fragrance. No hype.
Built for professional use with all red and near-infrared devices operating in the 630–850nm range. Compatible with panels, masks, wands, and clinical-grade equipment. Designed first and foremost to work with every Metamorphosis device in our FDA-cleared portfolio.
Why this matters for the category
The photobiomodulation market is growing rapidly — but the skincare formulated to work alongside LED devices has not kept pace with the science. SkinEXcellence Energize changes that. It is not a serum that happens to mention light therapy. It is a serum engineered around the precise biological mechanism that light therapy activates. That distinction is the foundation of our seven patent filings — and it is the standard every future Metamorphosis formulation will be held to.
What comes next for Metamorphosis
The seven patents filed in 2026 represent a pipeline, not a single product. The SkinEXcellence line will expand. The clinical ecosystem will deepen. And every step of that expansion will be held to the same standard that has defined Metamorphosis from the beginning — FDA clearance where required, independent clinical validation where applicable, and intellectual property protection where warranted.
We are building the science content infrastructure to match the clinical credibility we have spent years earning. And we are doing all of it the way we have always done it — without shortcuts, without compromises, and without ever confusing marketing language for scientific proof.
The beauty industry has enough confident claims. What it needs more of is accountable ones.
That is what Metamorphosis was built to provide. And that is what seven new patents are designed to protect.
Experience the clinical ecosystem today
While SkinEXcellence Energize is part of our 2026 pipeline, our award-winning exosome serum is available right now — a CosmoTrend Award winner for 2025 and the first product in our clinical companion skincare line.
Formulated to amplify the results of your Metamorphosis LED device, our exosome serum represents the same science-first philosophy that drives everything we make: ingredients chosen for biological function, not marketing appeal.
Shop our CosmoTrend Award-winning exosome serum →
Metamorphosis doesn’t follow beauty trends. It follows the science.
Sally Gardocki, Esquire
CEO & Founder, Metamorphosis Light Therapy, LLC
Charleston, South Carolina • 2026
